Physician

Stephani Dawn Christensen, M.D.

According to 2025 Medicare claims, Stephani Christensen, M.D. (NPI: 1285869727) practices medical oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89074-8195.

Christensen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 573 traditional Medicare patients, billed 103,782 HCPCS/CPT codes, and received $1,588,999 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,687 prescription claims across 296 beneficiaries totaling $1,231,429 in drug costs, led by Kisqali (Ribociclib Succinate). DME data shows 32 claims. Open Payments data shows 33 records totaling $46,777. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $12,487 to $1,588,999. Similarly, Part D prescription costs have risen steadily, from $37,120 to $1,231,429. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,923 to $6,185.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	27	181	$12,487
2016	122	15,026	$184,930
2017	449	90,499	$738,534
2018	576	141,592	$1,981,652
2019	673	213,075	$2,782,103
2020	634	181,589	$2,123,750
2021	603	107,106	$1,508,538
2022	633	136,671	$1,960,693
2023	614	136,386	$2,009,554
2024	573	103,782	$1,588,999

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	74	170	$37,120
2016	249	1,295	$828,321
2017	302	1,404	$1,068,040
2018	277	1,705	$1,183,714
2019	296	1,893	$1,444,017
2020	331	2,211	$1,674,649
2021	338	2,132	$1,616,053
2022	321	1,875	$1,224,758
2023	319	1,754	$1,265,652
2024	296	1,687	$1,231,429

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	11	53	$11,964
2019	11	61	$7,298
2020	N/R	39	$4,003
2021	N/R	110	$7,088
2022	N/R	215	$9,476
2023	N/R	144	$16,535
2024	N/R	32	$2,209

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	283	594	$95
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	272	601	$13
80053	Blood test, comprehensive group of blood chemicals	337	760	$10
36415	Insertion of needle into vein for collection of blood sample	382	971	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	378	982	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kisqali	Ribociclib Succinate	19	532	$295,284
Tagrisso	Osimertinib Mesylate	12	360	$198,856
Xtandi	Enzalutamide	13	390	$191,209
Ibrance	Palbociclib	13	280	$142,610
Eliquis	Apixaban	78	2,875	$52,179

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	12	$1,282
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	20	$927

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$225	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	16	$46,551	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stephani Dawn Christensen, M.D.?

Tedicare shows public-source Medicare data for Stephani Dawn Christensen, M.D. (NPI 1285869727), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephani Dawn Christensen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephani Dawn Christensen, M.D.?

Stephani Dawn Christensen, M.D. is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Stephani Dawn Christensen, M.D. have Open Payments data?

Stephani Dawn Christensen, M.D. has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.